A126 SAFETY OF COMBINATION BIOLOGIC AND IMMUNOSUPPRESSIVE THERAPY POST-ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW

机译：A126炎症性肠病患者的组合生物疗法和免疫抑制疗法后正畸肝移植的安全性：系统评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundInflammatory Bowel Disease (IBD) patients post orthotopic liver transplantation (OLT) often have ongoing mucosal inflammation necessitating biologic agents for therapy. The safety of combined biologic and immunosuppressive therapy post-OLT in this population is unclear.

机译：背景技术原位肝移植（OLT）后的炎症性肠病（IBD）患者经常患有持续的粘膜炎症，因此需要生物制剂进行治疗。 OLT后生物和免疫抑制联合治疗在该人群中的安全性尚不清楚。

著录项

期刊名称 Journal of the Canadian Association of Gastroenterology
作者
S Al Draiweesh; C Ma; M Alkhattabi; T Nguyen; M Brahmania; V Jairath;
展开▼
作者单位

展开▼
年(卷),期 2019(2),Suppl 2
年度 2019
页码 253–254
总页数 2
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease [J] . Inflammatory bowel diseases . 2020,第6期

机译：炎症性肠病患者肝脏移植组合生物和抗引发治疗的安全性
2. Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases [J] . Holmer Ariela, Singh Siddharth Expert review of clinical immunology . 2019,第7a12期

机译：炎症性肠病生物和免疫抑制治疗的总体和比较安全
3. Oral budesonide for the therapy of post-liver transplant de novo inflammatory bowel disease: a case series and systematic review of the literature. [J] . Barritt-AS 4th, Zacks SL, Rubinas TC, Inflammatory bowel diseases . 2008,第12期

机译：口服布地奈德治疗肝后移植新发性炎症性肠病：一个病例系列和文献系统的综述。
4. Natural anti-Inflammatory Compounds for the Management and Adjuvant Therapy of Inflammatory Bowel Disease (IBD) and its Drug Delivery System(DDS) for Targeted to Colon. [C] . Annual meeting exposition of the Controlled Release Society . 2009

机译：用于炎症性肠病（IBD）的管理和佐剂治疗的天然抗炎化合物及其药物递送系统（DDS）用于靶向结肠。
5. Oxidation Status as a Predictor of Disease Activity and Response to Therapy in Pediatric Patients with Inflammatory Bowel Disease [D] . Ajithkumar, Aravindh K. 2020

机译：氧化地位作为疾病活动的预测因素，对炎症性肠病儿科患者的疗法响应
6. A130 SAFETY OF COMBINATION BIOLOGIC AND ANTI-REJECTION THERAPY POST-LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: LONDON ONTARIO EXPERIENCE [O] . S Al Draiweesh, C Ma, M Alkhattabi, 2019

机译：A130炎症性肠病患者联合生物和抗排斥治疗肝移植后的安全性：伦敦安大略省的经验
7. A126 SAFETY OF COMBINATION BIOLOGIC AND IMMUNOSUPPRESSIVE THERAPY POST-ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW [O] . S Al Draiweesh, C Ma, M Alkhattabi, 2019

机译：A126组合生物和免疫抑制治疗的安全性和免疫抑制治疗炎症性肠病患者的原位肝移植：系统审查

A126 SAFETY OF COMBINATION BIOLOGIC AND IMMUNOSUPPRESSIVE THERAPY POST-ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW

摘要

著录项

相似文献

相关主题

期刊订阅